Your browser doesn't support javascript.
loading
Organoids in modelling infectious diseases.
Shpichka, Anastasia; Bikmulina, Polina; Peshkova, Maria; Heydari, Zahra; Kosheleva, Nastasia; Vosough, Massoud; Timashev, Peter.
Afiliación
  • Shpichka A; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia; Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia; Chemistry Department, Lomonosov Moscow State University, M
  • Bikmulina P; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia.
  • Peshkova M; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia; Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Heydari Z; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran.
  • Kosheleva N; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia; Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia; FSBSI 'Institute of General Pathology and Pathophysiology'
  • Vosough M; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran. Electronic address: masvos@royaninstitute.org.
  • Timashev P; World-Class Research Center 'Digital Biodesign and Personalized Healthcare', Sechenov First Moscow State Medical University, Moscow, Russia; Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia; Chemistry Department, Lomonosov Moscow State University, M
Drug Discov Today ; 27(1): 223-233, 2022 01.
Article en En | MEDLINE | ID: mdl-34418577
Approaches based on animal and two-dimensional (2D) cell culture models cannot ensure reliable results in modeling novel pathogens or in drug testing in the short term; therefore, there is rising interest in platforms such as organoids. To develop a toolbox that can be used successfully to overcome current issues in modeling various infections, it is essential to provide a framework of recent achievements in applying organoids. Organoids have been used to study viruses, bacteria, and protists that cause, for example, respiratory, gastrointestinal, and liver diseases. Their future as models of infection will be associated with improvements in system complexity, including abilities to model tissue structure, a dynamic microenvironment, and coinfection. Teaser. Organoids are a flexible tool for modelling viral, bacterial and protist infections. They can provide fast and reliable information on the biology of pathogens and in drug screening, and thus have become essential in combatting emerging infectious diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Organoides / Evaluación Preclínica de Medicamentos / Infecciones Tipo de estudio: Prognostic_studies Idioma: En Revista: Drug Discov Today Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Organoides / Evaluación Preclínica de Medicamentos / Infecciones Tipo de estudio: Prognostic_studies Idioma: En Revista: Drug Discov Today Año: 2022 Tipo del documento: Article